secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2025-04-08T23:59:59+00:00
Accession:  0001213900-25-029501
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed schedules special shareholder meeting for June 13, 2025
-------------------------------------------------------------

- Special meeting set for June 13, 2025; record dates for notice and voting both April 29, 2025.
- Meeting purpose not disclosed in the filing; shareholders await proxy materials for agenda.
- Notice filed via SEDAR in Canada; proxy materials will be sent using notice-and-access.
- Securities entitled to vote: Common Shares (ISIN CA4576377002).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390025029501/0001213900-25-029501-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390025029501/ea0237298-8k_inmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-029501

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer